BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Etc/GMT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T090000
DTEND;TZID=Etc/GMT:20241113T100000
DTSTAMP:20241109T105455Z
CREATED:20240729T210107Z
LAST-MODIFIED:20241109T105455Z
UID:10000229-1731488400-1731492000@www.lgcw.org.uk
SUMMARY:Oral cancer - causes\, early detection and prevention
DESCRIPTION:Register\nThis upcoming London Global Cancer Week (LGCW) C3 will be joined by Professor Warnakulasuriya – emeritus professor of Oral Medicine and Experimental Pathology at King’s College London – to discuss oral cancer\, it’s causes\, detection and prevention. \nAbout the speaker: \nProfessor Warnakulasuriya is an emeritus professor of Oral Medicine and Experimental Pathology at King’s College London\, UK and was the Chairman of the Oral Medicine Division at King’s College Hospital and at Guy’s Hospital\, London from 2005 -2015. He has made major contributions in cancer epidemiology\, oral medicine and experimental pathology. He is the Director of the WHO Collaborating Centre for Oral Cancer. Professor Warnakulasuriya received the IADR Distinguished Scientist Award in Oral Medicine and Pathology in 2014\, IADR Distinguished Scientist Award in Global Oral Health in 2022. He was elected a Fellow of King’s College London (FKC) for sustained and significant contributions to the College. He holds the Honorary Life Membership of the BSOM and International Association for Oral Pathologists. \nWhy oral cancer: \nOral cancer is the 13th most common cancer worldwide. Despite\, oral cancer being so prevalent and untreated dental caries (tooth decay) being the most common health condition according to the Global Burden of Disease 2019\, oral health is still often overlooked. Oral cancer is largely preventable and shares risk factors with other NCDs\, with tobacco and alcohol among the leading causes. C3 has long recognised the importance of tackling oral diseases including oral cancer through prevention and early detection as part of our mission to address NCDs. In fact\, since 2022 C3 have been working alongside Colgate\, the Commonwealth Nurses and Midwives Federation (CNMF)\, and the World Continuing Education Alliance (WCEA) as part of Colgate Bright Smiles\, Bright Futures\, to raise awareness about the importance of oral health for nurses and midwives and elevate the need for oral health education in practice. Learn more about C3’s oral health programmes.
URL:https://www.lgcw.org.uk/event/the-link-between-oral-health-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/C3-Collaborating.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T093000
DTEND;TZID=Etc/GMT:20241113T110000
DTSTAMP:20241112T234347Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241112T234347Z
UID:10000208-1731490200-1731495600@www.lgcw.org.uk
SUMMARY:Data on ALL\, Hodgkins and Wilms from Partner countries - improvement over time.
DESCRIPTION:Register\nThe Global Child Cancer subgroup of the Children’s Cancer and Leukaemia Group is made up of paediatric oncology doctors\, nurses and allied health professionals. Several paediatric oncology units have links with partner units in developing countries which have been present for many years. At this years London Cancer week we will present survival data on three key tumour types Leukaemia\, Hodgkins disease and Wilms tumour treatment highlighting the improvements that have happened over time. We will then discuss how data collection can be improved and what are the barriers to data collection.
URL:https://www.lgcw.org.uk/event/data-on-all-hodgkins-and-wilms-from-partner-countries-improvement-over-time/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/CCLG-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T110000
DTEND;TZID=Etc/GMT:20241113T120000
DTSTAMP:20241112T234347Z
CREATED:20241017T074508Z
LAST-MODIFIED:20241112T234347Z
UID:10000246-1731495600-1731499200@www.lgcw.org.uk
SUMMARY:Cancer Control through Tobacco Control in East Africa
DESCRIPTION:Register\nIn 2023\, Cancer Research UK and the Union for International Cancer Control launched a joint flagship programme in Kenya and Uganda with the aim of reducing the incidence of preventable cancers through effective tobacco control policies. Join us for this webinar during London Global Cancer Week\, hosted by Cancer Research UK\, to hear directly from Cancer Organisations working to build broad-based Tobacco Tax Coalitions who will be sharing their experiences\, challenges and opportunities in advocating for tobacco control\, and the importance of partnerships and coalition-building in these efforts\, as well as lessons from similar efforts supported by CRUK in in Sri Lanka and Nepal.  \nSpeakers: \nAlex Wright – Head of Global Policy & Programmes\, CRUK \nYannick Romero – Senior Knowledge & Advocacy Manager\, UICC \nPanellists: \nRachel Devotsu – McCabe Centre for Law and Cancer \nPhoebe Ongadi – Kenya Network of Cancer Organisation \nDennis Olodi – Uganda Cancer Society \nOlivia Stevens – KIVU International
URL:https://www.lgcw.org.uk/event/cancer-control-through-tobacco-control-in-east-africa/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/11/CRUK-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20250116T234104Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234104Z
UID:10000209-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:Opportunities to prevent liver cancer via urgent acceleration of viral hepatitis elimination
DESCRIPTION:Register\nWith almost a million new cases per year worldwide\, liver cancer is the sixth most common cancer globally\, with the highest rates of new cases and deaths seen in Asia and Africa. With the number of people diagnosed with or dying from liver cancer predicted to rise by 55% by 2040\, liver cancer will place an increasingly heavy burden on health systems across the world. \nThe two major hepatitis viruses—hepatitis B virus and hepatitis C virus—are oncogenic\, and viral hepatitis is a major cause of liver cancer. Despite the availability of an effective vaccine for hepatitis B and a cure for hepatitis C\, efforts to test and treat individuals for viral hepatitis and to prevent these infections are suboptimal. Ramping up these efforts is a critical component of cancer prevention that must be integrated and implemented into cancer prevention efforts globally. \nThe session provides the audience with the opportunity to learn more about the link between viral hepatitis and liver cancer\, and the key challenges facing efforts to eliminate viral hepatitis. The session will also focus on actionable aspects of hepatitis elimination with the end goal of preventing liver cancer.
URL:https://www.lgcw.org.uk/event/preventing-liver-cancer-through-eliminating-viral-hepatitis/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/Logos-for-LGCW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20241027T123607Z
CREATED:20241021T201403Z
LAST-MODIFIED:20241027T123607Z
UID:10000249-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:“Opportunities in Latin America for improving precision medicine in oncology”
DESCRIPTION:Register \nContext and Rationale \nCancer treatment has seen remarkable progress in recent years\, largely due to the advancements in precision medicine. This innovative approach enables personalized treatments that are tailored to the genetic and molecular characteristics of each patient’s tumor\, revolutionizing the way cancer is treated. With the help of precision diagnostics and genetic testing\, oncologists can now identify specific mutations that drive cancer growth\, paving the way for targeted therapies that are not only more effective but also less toxic than traditional treatments. These breakthroughs have led to significantly improved patient outcomes\, particularly in Europe and the United States\, where health systems have invested heavily in integrating these technologies into standard oncology care. \nIn regions like Europe and the U.S.\, organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology) have been at the forefront of research and clinical application of precision oncology. Experts in these organizations have helped shape the development and implementation of cutting-edge therapies\, as well as frameworks for precision diagnostics that have set a global benchmark. Their work has provided the foundation for clinical guidelines that support the integration of genetic profiling and biomarker-driven treatments in cancer care. These developments have not only enhanced treatment efficacy but also reduced the economic and physical burden of ineffective therapies. \nHowever\, while these advancements have become more commonplace in Europe and the U.S.\, Latin America faces significant challenges in replicating this progress. There are substantial gaps in infrastructure\, technology\, and funding across the region\, which hinder the adoption of precision medicine. Many countries lack the capacity for widespread genetic testing and molecular diagnostics\, and access to targeted therapies is often limited to a few specialized centers\, creating disparities in care. Additionally\, regulatory frameworks and reimbursement models are not yet fully equipped to support these innovations\, making it difficult for patients to benefit from the full spectrum of precision oncology. \nThis meeting aims to bring together the leading Cancer Institutes of Latin America\, along with key stakeholders and global experts\, to assess the current state of precision medicine in the region. The goal is to diagnose the situational challenges and explore the opportunities for improving cancer care through precision oncology. By drawing on the expertise of professionals involved in ASCO and ESMO\, the meeting will also serve as a platform to share international best practices\, promote collaboration\, and create actionable strategies for overcoming the region’s barriers to innovation. \nMeeting Objectives \n1. Assess the current state of precision medicine and diagnostics in the region: \nReview progress in using molecular diagnostics\, genetic testing\, and the implementation of targeted therapies across different cancer types in Latin America. Identify barriers to accessing these technologies. \n2. Share best practices in genetic testing and targeted therapies: \nFacilitate the exchange of successful experiences in using genetic testing to identify key mutations and selecting appropriate targeted therapies for each patient. \n3. Foster collaboration between cancer institutions: \nExplore cooperation among Cancer Institutes and other organizations to create networks that improve diagnostic capabilities\, share genetic data\, and enhance access to precision therapies. \n4. Develop regional strategies to improve access to precision medicine: \nDiscuss public policies\, funding\, and regulatory frameworks that will help increase the availability of genetic testing and access to targeted therapies \n5. Proposed Agenda Topics \n1. Overview of precision diagnostics and genetic testing in Latin America: \nThe current state of access to advanced molecular diagnostics\, genetic sequencing\, and laboratory capacities across the region. \n2. Advances in targeted therapies (target therapies): \nLatest innovations in the use of targeted therapies and how genetic tests help identify key biomarkers to personalize cancer treatment. \n3. Challenges and barriers to implementing genetic testing and access to precision therapies: \nIdentification of financial\, technological\, and regulatory obstacles that limit the use of genetic testing in clinical practice and access to targeted treatments. \n4. Collaboration and regional networks to enhance access to precision medicine: \nExploration of collaborative models between countries to improve early diagnosis\, data sharing\, and equitable access to targeted therapies. \n5. Public policy to promote precision medicine in oncology: \nProposals for policies that encourage investment in advanced diagnostic technologies and facilitate access to innovative treatments through subsidies\, insurance coverage\, and price regulation. \nExpected Outcomes \n• A current analysis of the state of precision medicine\, genetic testing\, and access to targeted therapies in Latin America. \n• Identification of the main barriers countries face in implementing precision diagnostics and using targeted therapies. \n• Proposals for inter-institutional collaboration to optimize the use of molecular diagnostic technologies and improve accessibility to personalized treatments. \n• Strategic recommendations to improve public policies that promote precision medicine in the region.
URL:https://www.lgcw.org.uk/event/opportunities-in-latin-america-for-improving-precision-medicine-in-oncology/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/selac-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T140000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T234004Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234004Z
UID:10000210-1731506400-1731511800@www.lgcw.org.uk
SUMMARY:Empowering Young Lives: Exploring the Global Impact\, Benefits\, and Insights of Xploro - An Innovative App Providing Essential Health Information on Childhood Cancer
DESCRIPTION:Register\nThe Xploro app uses gameplay and artificial intelligence to deliver essential health information to young patients and has been proven to strengthen coping mechanisms\, reduce anxiety\, improve procedural experiences and foster better long-term engagement with health services – all of which significantly improve health outcomes. \nThis session will feature a comprehensive demonstration of the Xploro app\, showcasing how it delivers critical health information to young patients in an engaging and accessible way. We will delve into the research underpinning the app’s impact\, highlighting its adaptation for use in low- and middle-income countries where World Child Cancer operates. \nAttendees will also hear firsthand experiences from child life specialists in Ghana and Malawi\, who will discuss the app’s impact on the children and families they support. This event is a unique opportunity to explore how innovative technology can enhance childhood cancer care and support the well-being of young patients globally.
URL:https://www.lgcw.org.uk/event/empowering-young-lives-exploring-the-global-impact-benefits-and-insights-of-xploro-an-innovative-app-providing-essential-health-information-on-childhood-cancer/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/world-child-cancer-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T143000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T232912Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T232912Z
UID:10000211-1731508200-1731511800@www.lgcw.org.uk
SUMMARY:Achieving population-based palliative care: Learnings from Telangana\, India
DESCRIPTION:Register\nJoin Drs. Gayatri Palat and Gillian Fyles\, Mr. Swarup Immaraju\, and Ms. Vineela Rapelli as they discuss the road to achieving population-based palliative care in Telangana. \nAccess to effective and affordable palliative and end-of-life care for those with life-limiting diseases\, including cancer\, in lesser–resourced countries is limited\, resulting in a high burden of distress due to pain\, symptoms\, stigma\, isolation\, and financial compromise. \nThis presentation will address how Telangana\, a state in southern India\, moved from an absence of palliative care in the early 2000’s to a current\, internationally recognized palliative care program serving 38 million people in 33 administrative districts. The steps involved in creating this capacity and the key factors underlying successful implementation\, will be presented\, along with a roadmap for implementation that can be replicated elsewhere. We will describe how a collaboration between a state government and Indian and Canadian NGOs resulted in palliative care now being accessible to all\, including in the poorest and the remotest areas of the state.
URL:https://www.lgcw.org.uk/event/achieving-population-based-palliative-care-learnings-from-telangana-india/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2022/05/two-worlds-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T150000
DTEND;TZID=Etc/GMT:20241113T160000
DTSTAMP:20241112T234348Z
CREATED:20240807T202815Z
LAST-MODIFIED:20241112T234348Z
UID:10000232-1731510000-1731513600@www.lgcw.org.uk
SUMMARY:Introducing Cardio-Oncology: A Vital Addition for the Cancer Journey
DESCRIPTION:Register\nWith the increasing efficacy of cancer therapies concerns for quality of life continue to grow. Cardiovascular health is recognized as one of the most important areas for patients with cancer and survivors to pay attention to. This session will provide an overview of this developing field including some global perspectives.
URL:https://www.lgcw.org.uk/event/introducing-cardio-oncology-a-vital-addition-for-the-cancer-journey/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/international-Cardio-Oncology-Society.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T153000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241112T234348Z
CREATED:20241004T081029Z
LAST-MODIFIED:20241112T234348Z
UID:10000243-1731511800-1731517200@www.lgcw.org.uk
SUMMARY:Impact of climate change in cancer care: experiences around the globe.
DESCRIPTION:Register\nThe webinar aims to increase awareness of the impact of climate change on patients and healthcare professionals;  and highlight ways in which the climate impacts of healthcare can be reduced\, and the role of clinical trials in this endeavour.  This involves discussion of the importance of climate change in cancer care\, testimonies from oncologists of the challenges for patients and providers in climate change impacted areas\, and solution focused talks on sustainability integration into patient care and clinical research. \nRunning Order: \n1. Welcome (Eduardo L. Cazap\, SLACOM) \n2.Introduction about climate change (Joan Schiller\, OUCH-I) \n3. Impact on patients and providers – \na. Experience from Brazil (Gustavo Gossling\, LACOG) \nb. Experience from Nigeria ( Olubukola Ayodele\, University Hospitals of Leicester NHS Trust\, UK ) \nc. Experience from The Philippines (Dr Roselle De Guzman\, Manila Central University-FDT Medical Foundation Hospital) \n4. Tool kits \na. Clinical trials (Lisa Fox\, The Institute of Cancer Research) \nb. Medical Oncology (Seamus O’Reilly\, Cancer Trials Ireland) \nc. Radiotherapy\, (Katie Lichter\, (University of California\, San Francisco\, USA)) \nd. Surgery\, (Shelley Hwang\, Duke University)
URL:https://www.lgcw.org.uk/event/impact-of-climate-change-in-cancer-care-experiences-around-the-globe-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/Logos-together-LGCW-Claire-Hopkins.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241231T005840Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241231T005840Z
UID:10000213-1731513600-1731517200@www.lgcw.org.uk
SUMMARY:Every facility\, every country: SIOP Global Mapping of Paediatric Oncology Services
DESCRIPTION:Register\nThe SIOP Global Mapping Programme of Paediatric Oncology Services has the potential to benefit everyone\, especially the children\, adolescents\, and young adults for whom we care. Mapping allows us to know where care is being delivered\, by whom and with which resources. \nWe will present the current landscape of paediatric oncology services around the world and the benefits and challenges of mapping. Join us to learn about the power of mapping for professionals\, patients and families\, governments\, non-governmental organizations\, and other key stakeholders.
URL:https://www.lgcw.org.uk/event/every-facility-every-country-siop-global-mapping-of-paediatric-oncology-services/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/SIOP-global-mapping.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241230T205652Z
CREATED:20240823T182243Z
LAST-MODIFIED:20241230T205652Z
UID:10000238-1731513600-1731517200@www.lgcw.org.uk
SUMMARY:Global Disparities in Supportive Care in Cancer\, one size does not fit all
DESCRIPTION:Register\nEducational Objectives: \n-Understand the differing definitions and issues related to healthcare disparities across regions of the world. \n-Analyse the different perspectives from global stakeholders regarding the most important issues related with cancer supportive care. \n-Apply the knowledge obtained form the webinar to better understand the way in which to evaluate the local disparities in supportive care in cancer and the possibilities to interact with other stakeholders to tackle these disparities.
URL:https://www.lgcw.org.uk/event/global-disparities-in-supportive-care-in-cancer-one-size-does-not-fit-all/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/MASCC-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T173000
DTSTAMP:20250120T212229Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250120T212229Z
UID:10000212-1731513600-1731519000@www.lgcw.org.uk
SUMMARY:Women\, Power\, and Cancer - NCI Session at LGCW 2024
DESCRIPTION:Register\nThe Lancet Commission on Women\, Power\, and Cancer addresses urgent questions at the intersection of social inequality\, cancer risk and outcomes\, and the status of women in society. A year out from the publication of the 2023 Commission report\, the NCI convenes this London Global Cancer Week session to review progress made and discuss plans for evaluation\, patient engagement\, and opportunities for further research.
URL:https://www.lgcw.org.uk/event/a-framework-for-monitoring-progress-at-the-intersection-of-women-power-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/NCI-event.png
END:VEVENT
END:VCALENDAR